Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02KPJ
|
|||
| Drug Name |
UCART19
|
|||
| Indication | Burkitt cell leukaemia [ICD-11: 2A85.6; ICD-10: C83.7, C91.8] | Phase 1 | [1] | |
| Company |
Allogene Therapeutics South San Francisco, CA ServierParis, France
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.